Viewpoints

Addressing antimicrobial resistance for better care in cancer patients – by Yehoda M. Martei and Shalini J. Zürn

Infections in cancer patients are a very common complication making the routine use of antibiotics lifesaving in the treatment of these patients. As many as 1 in 5 cancer patients undergoing treatment will need antibiotics during their treatment1. Infections in cancer patients may be related to an immunosuppressed state due to alteration of the underlying immune system caused by the primary cancer, as is the case in some hematologic malignancies.